A citation-based method for searching scientific literature

André O von Bueren, Rolf-Dieter Kortmann, Katja von Hoff, Carsten Friedrich, Martin Mynarek, Klaus Müller, Tobias Goschzik, Anja Zur Mühlen, Nicolas Gerber, Monika Warmuth-Metz, Niels Soerensen, Frank Deinlein, Martin Benesch, Isabella Zwiener, Robert Kwiecien, Andreas Faldum, Udo Bode, Gudrun Fleischhack, Volker Hovestadt, Marcel Kool, David Jones, Paul Northcott, Joachim Kuehl, Stefan Pfister, Torsten Pietsch, Stefan Rutkowski. J Clin Oncol 2016
Times Cited: 72







List of co-cited articles
603 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Molecular subgroups of medulloblastoma: the current consensus.
Michael D Taylor, Paul A Northcott, Andrey Korshunov, Marc Remke, Yoon-Jae Cho, Steven C Clifford, Charles G Eberhart, D Williams Parsons, Stefan Rutkowski, Amar Gajjar,[...]. Acta Neuropathol 2012
55

Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.
Vijay Ramaswamy, Marc Remke, Eric Bouffet, Simon Bailey, Steven C Clifford, Francois Doz, Marcel Kool, Christelle Dufour, Gilles Vassal, Till Milde,[...]. Acta Neuropathol 2016
305
52

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.
Amar Gajjar, Murali Chintagumpala, David Ashley, Stewart Kellie, Larry E Kun, Thomas E Merchant, Shaio Woo, Greg Wheeler, Valerie Ahern, Matthew J Krasin,[...]. Lancet Oncol 2006
592
51

Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
Roger J Packer, Amar Gajjar, Gilbert Vezina, Lucy Rorke-Adams, Peter C Burger, Patricia L Robertson, Lisa Bayer, Deborah LaFond, Bernadine R Donahue, MaryAnne H Marymont,[...]. J Clin Oncol 2006
578
48

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
41

Medulloblastoma comprises four distinct molecular variants.
Paul A Northcott, Andrey Korshunov, Hendrik Witt, Thomas Hielscher, Charles G Eberhart, Stephen Mack, Eric Bouffet, Steven C Clifford, Cynthia E Hawkins, Pim French,[...]. J Clin Oncol 2011
852
41

Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas.
Marcel Kool, Andrey Korshunov, Marc Remke, David T W Jones, Maria Schlanstein, Paul A Northcott, Yoon-Jae Cho, Jan Koster, Antoinette Schouten-van Meeteren, Dannis van Vuurden,[...]. Acta Neuropathol 2012
611
40

Intertumoral Heterogeneity within Medulloblastoma Subgroups.
Florence M G Cavalli, Marc Remke, Ladislav Rampasek, John Peacock, David J H Shih, Betty Luu, Livia Garzia, Jonathon Torchia, Carolina Nor, A Sorana Morrissy,[...]. Cancer Cell 2017
510
38

Novel molecular subgroups for clinical classification and outcome prediction in childhood medulloblastoma: a cohort study.
Edward C Schwalbe, Janet C Lindsey, Sirintra Nakjang, Stephen Crosier, Amanda J Smith, Debbie Hicks, Gholamreza Rafiee, Rebecca M Hill, Alice Iliasova, Thomas Stone,[...]. Lancet Oncol 2017
259
36

Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial.
Birgitta Lannering, Stefan Rutkowski, Francois Doz, Barry Pizer, Göran Gustafsson, Aurora Navajas, Maura Massimino, Roel Reddingius, Martin Benesch, Christian Carrie,[...]. J Clin Oncol 2012
169
34

Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma.
Nataliya Zhukova, Vijay Ramaswamy, Marc Remke, Elke Pfaff, David J H Shih, Dianna C Martin, Pedro Castelo-Branco, Berivan Baskin, Peter N Ray, Eric Bouffet,[...]. J Clin Oncol 2013
268
31

Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis.
Eric M Thompson, Thomas Hielscher, Eric Bouffet, Marc Remke, Betty Luu, Sridharan Gururangan, Roger E McLendon, Darell D Bigner, Eric S Lipp, Sebastien Perreault,[...]. Lancet Oncol 2016
166
31

Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.
P M Zeltzer, J M Boyett, J L Finlay, A L Albright, L B Rorke, J M Milstein, J C Allen, K R Stevens, P Stanley, H Li,[...]. J Clin Oncol 1999
511
30

Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study.
Regina I Jakacki, Peter C Burger, Tianni Zhou, Emiko J Holmes, Mehmet Kocak, Arzu Onar, Joel Goldwein, Minesh Mehta, Roger J Packer, Nancy Tarbell,[...]. J Clin Oncol 2012
106
30

Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.
Yoon-Jae Cho, Aviad Tsherniak, Pablo Tamayo, Sandro Santagata, Azra Ligon, Heidi Greulich, Rameen Berhoukim, Vladimir Amani, Liliana Goumnerova, Charles G Eberhart,[...]. J Clin Oncol 2011
472
29

Cytogenetic prognostication within medulloblastoma subgroups.
David J H Shih, Paul A Northcott, Marc Remke, Andrey Korshunov, Vijay Ramaswamy, Marcel Kool, Betty Luu, Yuan Yao, Xin Wang, Adrian M Dubuc,[...]. J Clin Oncol 2014
172
27

The whole-genome landscape of medulloblastoma subtypes.
Paul A Northcott, Ivo Buchhalter, A Sorana Morrissy, Volker Hovestadt, Joachim Weischenfeldt, Tobias Ehrenberger, Susanne Gröbner, Maia Segura-Wang, Thomas Zichner, Vasilisa A Rudneva,[...]. Nature 2017
469
27

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.
Giles W Robinson, Brent A Orr, Gang Wu, Sridharan Gururangan, Tong Lin, Ibrahim Qaddoumi, Roger J Packer, Stewart Goldman, Michael D Prados, Annick Desjardins,[...]. J Clin Oncol 2015
240
25

Novel mutations target distinct subgroups of medulloblastoma.
Giles Robinson, Matthew Parker, Tanya A Kranenburg, Charles Lu, Xiang Chen, Li Ding, Timothy N Phoenix, Erin Hedlund, Lei Wei, Xiaoyan Zhu,[...]. Nature 2012
563
25

beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee.
David W Ellison, Olabisi E Onilude, Janet C Lindsey, Meryl E Lusher, Claire L Weston, Roger E Taylor, Andrew D Pearson, Steven C Clifford. J Clin Oncol 2005
296
25

Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.
Marcel Kool, David T W Jones, Natalie Jäger, Paul A Northcott, Trevor J Pugh, Volker Hovestadt, Rosario M Piro, L Adriana Esparza, Shirley L Markant, Marc Remke,[...]. Cancer Cell 2014
451
23

Treatment of early childhood medulloblastoma by postoperative chemotherapy alone.
Stefan Rutkowski, Udo Bode, Frank Deinlein, Holger Ottensmeier, Monika Warmuth-Metz, Niels Soerensen, Norbert Graf, Angela Emser, Torsten Pietsch, Johannes E A Wolff,[...]. N Engl J Med 2005
480
23

Dissecting the genomic complexity underlying medulloblastoma.
David T W Jones, Natalie Jäger, Marcel Kool, Thomas Zichner, Barbara Hutter, Marc Sultan, Yoon-Jae Cho, Trevor J Pugh, Volker Hovestadt, Adrian M Stütz,[...]. Nature 2012
583
22


Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features.
Marcel Kool, Jan Koster, Jens Bunt, Nancy E Hasselt, Arjan Lakeman, Peter van Sluis, Dirk Troost, Netteke Schouten-van Meeteren, Huib N Caron, Jacqueline Cloos,[...]. PLoS One 2008
504
22

Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91.
Katja von Hoff, Bernward Hinkes, Nicolas U Gerber, Frank Deinlein, Uwe Mittler, Christian Urban, Martin Benesch, Monika Warmuth-Metz, Niels Soerensen, Isabella Zwiener,[...]. Eur J Cancer 2009
131
22

Subgroup-specific structural variation across 1,000 medulloblastoma genomes.
Paul A Northcott, David J H Shih, John Peacock, Livia Garzia, A Sorana Morrissy, Thomas Zichner, Adrian M Stütz, Andrey Korshunov, Jüri Reimand, Steven E Schumacher,[...]. Nature 2012
561
20


Medulloblastoma Genotype Dictates Blood Brain Barrier Phenotype.
Timothy N Phoenix, Deanna M Patmore, Scott Boop, Nidal Boulos, Megan O Jacus, Yogesh T Patel, Martine F Roussel, David Finkelstein, Liliana Goumnerova, Sebastien Perreault,[...]. Cancer Cell 2016
153
19

Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.
Trevor J Pugh, Shyamal Dilhan Weeraratne, Tenley C Archer, Daniel A Pomeranz Krummel, Daniel Auclair, James Bochicchio, Mauricio O Carneiro, Scott L Carter, Kristian Cibulskis, Rachel L Erlich,[...]. Nature 2012
524
19

Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis.
Vijay Ramaswamy, Marc Remke, Eric Bouffet, Claudia C Faria, Sebastien Perreault, Yoon-Jae Cho, David J Shih, Betty Luu, Adrian M Dubuc, Paul A Northcott,[...]. Lancet Oncol 2013
224
19

Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High-Dose Chemotherapy.
Lucie Lafay-Cousin, Amy Smith, Susan N Chi, Elizabeth Wells, Jennifer Madden, Ashley Margol, Vijay Ramaswamy, Jonathan Finlay, Michael D Taylor, Girish Dhall,[...]. Pediatr Blood Cancer 2016
68
20

High-risk medulloblastoma: a pediatric oncology group randomized trial of chemotherapy before or after radiation therapy (POG 9031).
Nancy J Tarbell, Henry Friedman, William R Polkinghorn, Torunn Yock, Tianni Zhou, Zhengjia Chen, Peter Burger, Patrick Barnes, Larry Kun. J Clin Oncol 2013
89
19

Biomarker-driven stratification of disease-risk in non-metastatic medulloblastoma: Results from the multi-center HIT-SIOP-PNET4 clinical trial.
Steven C Clifford, Birgitta Lannering, Ed C Schwalbe, Debbie Hicks, Kieran O'Toole, Sarah Leigh Nicholson, Tobias Goschzik, Anja Zur Mühlen, Dominique Figarella-Branger, François Doz,[...]. Oncotarget 2015
36
38

Hyperfractionated accelerated radiotherapy in the Milan strategy for metastatic medulloblastoma.
Lorenza Gandola, Maura Massimino, Graziella Cefalo, Carlo Solero, Filippo Spreafico, Emilia Pecori, Daria Riva, Paola Collini, Emanuele Pignoli, Felice Giangaspero,[...]. J Clin Oncol 2009
90
19

Treatment of young children with localized medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology.
André O von Bueren, Katja von Hoff, Torsten Pietsch, Nicolas U Gerber, Monika Warmuth-Metz, Frank Deinlein, Isabella Zwiener, Andreas Faldum, Gudrun Fleischhack, Martin Benesch,[...]. Neuro Oncol 2011
105
19

Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.
David W Ellison, James Dalton, Mehmet Kocak, Sarah Leigh Nicholson, Charles Fraga, Geoff Neale, Anna M Kenney, Dan J Brat, Arie Perry, William H Yong,[...]. Acta Neuropathol 2011
339
18

Medulloblastoma subgroup-specific outcomes in irradiated children: who are the true high-risk patients?
Vijay Ramaswamy, Marc Remke, Jennifer Adamski, Ute Bartels, Uri Tabori, Xin Wang, Annie Huang, Cynthia Hawkins, Donald Mabbott, Normand Laperriere,[...]. Neuro Oncol 2016
82
18

Medulloblastomics: the end of the beginning.
Paul A Northcott, David T W Jones, Marcel Kool, Giles W Robinson, Richard J Gilbertson, Yoon-Jae Cho, Scott L Pomeroy, Andrey Korshunov, Peter Lichter, Michael D Taylor,[...]. Nat Rev Cancer 2012
409
18

HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma.
Yanxin Pei, Kun-Wei Liu, Jun Wang, Alexandra Garancher, Ran Tao, Lourdes A Esparza, Donna L Maier, Yoko T Udaka, Najiba Murad, Sorana Morrissy,[...]. Cancer Cell 2016
144
18

Divergent clonal selection dominates medulloblastoma at recurrence.
A Sorana Morrissy, Livia Garzia, David J H Shih, Scott Zuyderduyn, Xi Huang, Patryk Skowron, Marc Remke, Florence M G Cavalli, Vijay Ramaswamy, Patricia E Lindsay,[...]. Nature 2016
193
18

Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
R J Packer, J Goldwein, H S Nicholson, L G Vezina, J C Allen, M D Ris, K Muraszko, L B Rorke, W M Wara, B H Cohen,[...]. J Clin Oncol 1999
410
18

Subtypes of medulloblastoma have distinct developmental origins.
Paul Gibson, Yiai Tong, Giles Robinson, Margaret C Thompson, D Spencer Currle, Christopher Eden, Tanya A Kranenburg, Twala Hogg, Helen Poppleton, Julie Martin,[...]. Nature 2010
527
18

Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort.
Torsten Pietsch, Rene Schmidt, Marc Remke, Andrey Korshunov, Volker Hovestadt, David T W Jones, Jörg Felsberg, Kerstin Kaulich, Tobias Goschzik, Marcel Kool,[...]. Acta Neuropathol 2014
84
18

Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations.
Margaret C Thompson, Christine Fuller, Twala L Hogg, James Dalton, David Finkelstein, Ching C Lau, Murali Chintagumpala, Adekunle Adesina, David M Ashley, Stewart J Kellie,[...]. J Clin Oncol 2006
485
18


Survival and prognostic factors of early childhood medulloblastoma: an international meta-analysis.
Stefan Rutkowski, Katja von Hoff, Angela Emser, Isabella Zwiener, Torsten Pietsch, Dominique Figarella-Branger, Felice Giangaspero, David W Ellison, Maria-Luisa Garre, Veronica Biassoni,[...]. J Clin Oncol 2010
179
18

Medulloblastoma.
Paul A Northcott, Giles W Robinson, Christian P Kratz, Donald J Mabbott, Scott L Pomeroy, Steven C Clifford, Stefan Rutkowski, David W Ellison, David Malkin, Michael D Taylor,[...]. Nat Rev Dis Primers 2019
201
18

Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.
Paul A Northcott, Catherine Lee, Thomas Zichner, Adrian M Stütz, Serap Erkek, Daisuke Kawauchi, David J H Shih, Volker Hovestadt, Marc Zapatka, Dominik Sturm,[...]. Nature 2014
350
16

BET bromodomain inhibition of MYC-amplified medulloblastoma.
Pratiti Bandopadhayay, Guillaume Bergthold, Brian Nguyen, Simone Schubert, Sharareh Gholamin, Yujie Tang, Sara Bolin, Steven E Schumacher, Rhamy Zeid, Sabran Masoud,[...]. Clin Cancer Res 2014
222
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.